The MTP -493TT genotype is associated with peripheral arterial disease: Results from the Linz Peripheral Arterial Disease (LIPAD) Study

Clinical Biochemistry

Volumn 41, Issue 9, 2008, Pages 712-716

  Schgoer, Wilfried ^a   Eller, Philipp ^a   Mueller, Thomas ^b   Tancevski, Ivan ^a   Wehinger, Andreas ^a   Ulmer, Hanno ^c   Sandhofer, Anton ^a   Ritsch, Andreas ^a   Haltmayer, Meinhard ^b   Patsch, Josef R ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

MTP; Peripheral vascular disease; Polymorphism; Risk factors

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HOMOCYSTEINE; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; TRIACYLGLYCEROL;

ARTERY DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; GENE FREQUENCY; GENOTYPE; HYPERTENSION; LIPID ANALYSIS; LIPID TRANSPORT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; CARRIER PROTEINS; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 43449099411     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.02.007     Document Type: Article

References (29)

1. Gordon D.A., Jamil H., Sharp D., et al. Secretion of apolipoprotein B-containing lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability. Proc Natl Acad Sci U S A 91 (1994) 7628-7632
2. Leiper J.M., Bayliss J.D., Pease R.J., Brett D.J., Scott J., and Shoulders C.C. Microsomal triglyceride transfer protein, the abetalipoproteinemia gene product, mediates the secretion of apolipoprotein B-containing lipoproteins from heterologous cells. J Biol Chem 269 (1994) 21951-21954
3. Boren J., Veniant M.M., and Young S.G. Apo B100-containing lipoproteins are secreted by the heart. J Clin Invest 101 (1998) 1197-1202
4. Wetterau J.R., Combs K.A., Spinner S.N., and Joiner B.J. Protein disulfide isomerase is a component of the microsomal triglyceride transfer protein complex. J Biol Chem 265 (1990) 9801-9807
5. Karpe F., Lundahl B., Ehrenborg E., Eriksson P., and Hamsten A. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler Thromb Vasc Biol 18 (1998) 756-761
6. Juo S.H., Han Z., Smith J.D., Colangelo L., and Liu K. Common polymorphism in promoter of microsomal triglyceride transfer protein gene influences cholesterol, ApoB, and triglyceride levels in young African American men: results from the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol 20 (2000) 1316-1322
7. Couture P., Otvos J.D., Cupples L.A., Wilson P.W., Schaefer E.J., and Ordovas J.M. Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study. Atherosclerosis 148 (2000) 337-343
8. Herrmann S.M., Poirier O., Nicaud V., et al. Identification of two polymorphisms in the promoter of the microsomal triglyceride transfer protein (MTP) gene: lack of association with lipoprotein profiles. J Lipid Res 39 (1998) 2432-2435
9. St-Pierre J., Lemieux I., Miller-Felix I., et al. Visceral obesity and hyperinsulinemia modulate the impact of the microsomal triglyceride transfer protein -493G/T polymorphism on plasma lipoprotein levels in men. Atherosclerosis 160 (2002) 317-324
10. Berthier M.T., Houde A., Paradis A.M., et al. Molecular screening of the microsomal triglyceride transfer protein: association between polymorphisms and both abdominal obesity and plasma apolipoprotein B concentration. J Hum Genet 49 (2004) 684-690
11. Ledmyr H., McMahon A.D., Ehrenborg E., et al. The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease. Circulation 109 (2004) 2279-2284
12. Cuchel M., Bloedon L.T., Szapary P.O., et al. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N Engl J Med 356 (2007) 148-156
13. Wetterau J.R., Gregg R.E., Harrity T.W., et al. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science 282 (1998) 751-754
14. Leung G.K., Veniant M.M., Kim S.K., et al. A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion. J Biol Chem 275 (2000) 7515-7520
15. Raabe M., Veniant M.M., Sullivan M.A., et al. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest 103 (1999) 1287-1298
16. Tietge U.J., Bakillah A., Maugeais C., Tsukamoto K., Hussain M., and Rader D.J. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J Lipid Res 40 (1999) 2134-2139
17. Mueller T., Marschon R., Dieplinger B., et al. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study. J Vasc Surg 41 (2005) 808-815
18. Rutherford R.B., Baker J.D., Ernst C., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
19. Juo S.H., Colangelo L., Han Z., Smith J.D., and Liu K. Confirmation of the microsomal triglyceride transfer protein genetic effect on lipids in young African American men from the CARDIA study. Arterioscler Thromb Vasc Biol 23 (2003) 912-913
20. Lally S., Tan C.Y., Owens D., and Tomkin G.H. Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein. Diabetologia 49 (2006) 1008-1016
21. Phillips C., Mullan K., Owens D., and Tomkin G.H. Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition. Atherosclerosis 187 (2006) 57-64
22. Geesaman B.J., Benson E., Brewster S.J., et al. Haplotype-based identification of a microsomal transfer protein marker associated with the human lifespan. Proc Natl Acad Sci U S A 100 (2003) 14115-14120
23. Beekman M., Blauw G.J., Houwing-Duistermaat J.J., Brandt B.W., Westendorp R.G., and Slagboom P.E. Chromosome 4q25, microsomal transfer protein gene, and human longevity: novel data and a meta-analysis of association studies. J Gerontol A Biol Sci Med Sci 61 (2006) 355-362
24. Nebel A., Croucher P.J., Stiegeler R., Nikolaus S., Krawczak M., and Schreiber S. No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans. Proc Natl Acad Sci U S A 102 (2005) 7906-7909
25. Lundahl B., Skoglund-Andersson C., Caslake M., et al. Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles. Am J Physiol Endocrinol Metab 290 (2006) E739-E745
26. Vincent S., Planells R., Defoort C., et al. Genetic polymorphisms and lipoprotein responses to diets. Proc Nutr Soc 61 (2002) 427-434
27. Lopez-Miranda J., Perez-Martinez P., Marin C., Moreno J.A., Gomez P., and Perez-Jimenez F. Postprandial lipoprotein metabolism, genes and risk of cardiovascular disease. Curr Opin Lipidol 17 (2006) 132-138
28. Lundahl B., Hamsten A., and Karpe F. Postprandial plasma ApoB-48 levels are influenced by a polymorphism in the promoter of the microsomal triglyceride transfer protein gene. Arterioscler Thromb Vasc Biol 22 (2002) 289-293
29. Phillips C., Mullan K., Owens D., and Tomkin G.H. Microsomal triglyceride transfer protein polymorphisms and lipoprotein levels in type 2 diabetes. Qjm 97 (2004) 211-218